ストックスクリーナーアプリを入手
10.38
2.36%
0.205
前日終値:
$10.17
開ける：
$10.15
24時間の取引高:
376.58K
Relative Volume:
0.19
時価総額：
$1.52B
収益：
-
当期純損益:
$-174.61M
株価収益率:
-5.2665
EPS:
-1.97
ネットキャッシュフロー:
$-165.54M
1週間 パフォーマンス:
+12.78%
1か月 パフォーマンス:
+19.24%
6か月 パフォーマンス:
+25.42%
1年 パフォーマンス:
+25.42%
1日の値動き範囲:
$10.12
$10.50
1週間の範囲:
$9.115
$10.50
52週間の値動き範囲:
$4.16
$11.84
89 Bio Inc Stock (ETNB) Company Profile
ETNB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
10.39 | 1.34B | 0 | -174.61M | -165.54M | -1.97 |
|
ONC
Beone Medicines Ltd Adr
|
258.98 | 26.01B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.65 | 114.53B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.39 | 40.54M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
85.59 | 6.29B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
496.05 | 65.13B | 14.09B | 4.50B | 2.96B | 39.28 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-14 | 開始されました | Goldman | Neutral |
| 2025-03-13 | 開始されました | Citigroup | Buy |
| 2025-02-04 | 開始されました | Wolfe Research | Outperform |
| 2024-04-22 | 再開されました | BofA Securities | Buy |
| 2024-01-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2023-08-28 | 開始されました | UBS | Buy |
| 2023-06-13 | 開始されました | Evercore ISI | Outperform |
| 2022-05-12 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-26 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-07-29 | 再開されました | BTIG Research | Buy |
| 2021-05-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-10-19 | 開始されました | Raymond James | Strong Buy |
| 2020-09-25 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-07-31 | 開始されました | Piper Sandler | Overweight |
| 2020-07-23 | 開始されました | BTIG Research | Buy |
| 2020-07-07 | 開始されました | Chardan Capital Markets | Buy |
| 2019-12-09 | 開始されました | BofA/Merrill | Neutral |
| 2019-12-09 | 開始されました | Oppenheimer | Outperform |
| 2019-12-09 | 開始されました | RBC Capital Mkts | Outperform |
| 2019-12-09 | 開始されました | SVB Leerink | Outperform |
すべてを表示
89 Bio Inc (ETNB) 最新ニュース
Nuveen Asset Management LLC Sells 3,420 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Two Sigma Investments LP Sells 131,167 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Shares Bought by Bank of America Corp DE - Defense World
ProShare Advisors LLC Raises Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Holdings Raised by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
89bio, Inc. (NASDAQ:ETNB) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
89bio holds annual meeting, directors elected By Investing.com - Investing.com Canada
89bio Elects Directors and Approves Proposals at Annual Meeting - TipRanks
89bio holds annual meeting, directors elected - Investing.com
89bio Inc (NASDAQ: ETNB) Is A Blank Check For Growth - Stocksregister
Deutsche Bank AG Has $610,000 Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Millennium Management LLC Has $5.54 Million Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio (ETNB) Price Target Slightly Reduced by BofA, Buy Rating M - GuruFocus
89bio (ETNB) Price Target Slightly Reduced by BofA, Buy Rating Maintained | ETNB Stock News - GuruFocus
89bio price target lowered to $30 from $31 at BofA - TipRanks
89bio’s (ETNB) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World
Is 89bio (NASDAQ:ETNB) A Risky Investment? - simplywall.st
Northern Trust Corp Increases Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
BNP Paribas Financial Markets Takes Position in 89bio, Inc. (NASDAQ:ETNB) - The AM Reporter
Will Other Major MASH Deals Follow GSK/Boston Pharma? - insights.citeline.com
Dimensional Fund Advisors LP Buys New Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Stock Holdings Increased by Price T Rowe Associates Inc. MD - Defense World
Voya Investment Management LLC Sells 1,476 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Why 89bio, Inc. (ETNB) Is Among the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance
Hsbc Holdings PLC Invests $87,000 in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Weiss Ratings Reaffirms “Sell (D-)” Rating for 89bio (NASDAQ:ETNB) - Defense World
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ETNB Stock News - GuruFocus
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
89bio, Inc. (NASDAQ:ETNB) Receives $27.25 Consensus Target Price from Analysts - Defense World
Deeper Dive: Understanding 89bio Inc (ETNB) Through its Various Ratios - DWinneX
MetLife Investment Management LLC Raises Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio to Participate in Upcoming Investor Conferences - The Manila Times
89bio Schedules Double Fireside Chats: Key Updates Coming at Major Healthcare Conferences - Stock Titan
89bio Inc. Reports Q1 2025 Financial Results - TipRanks
Invesco Ltd. Acquires 3,893 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Wells Fargo & Company MN Has $394,000 Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Brokers Offer Predictions for 89bio FY2025 Earnings - Defense World
Decoding 89bio Inc (ETNB): A Strategic SWOT Insight - GuruFocus
89bio, Inc. SEC 10-Q Report - TradingView
89bio Inc [NASDAQ: ETNB] Sees Increase in Stock Value - knoxdaily.com
Cantor Fitzgerald cuts 89bio stock target to $55; keeps overweight By Investing.com - Investing.com Nigeria
Cantor Fitzgerald cuts 89bio stock target to $55; keeps overweight - Investing.com
89bio (ETNB) Poised for Success with Advancements in MASH Trials - GuruFocus
Cantor Fitzgerald Upgrades 89bio (NASDAQ:ETNB) to “Strong-Buy” - Defense World
89bio Reports First Quarter 2025 Financial Results and Corporate Updates - The Manila Times
There is no doubt that 89bio Inc (ETNB) ticks all the boxes. - Sete News
Insider’s View: Deciphering 89bio Inc (ETNB)’s Financial Health Through Ratios - DWinneX
Taking a Closer Look At 89bio Inc (ETNB) Following Its Recent Trade - knoxdaily.com
Legal & General Group Plc Sells 4,860 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Holdings Trimmed by Russell Investments Group Ltd. - Defense World
89 Bio Inc (ETNB) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
0.19%
大文字化:
|
ボリューム (24 時間):